{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16(6)"],"submitter":["Park J"],"funding":["Ministry of Science and ICT","National Research Foundation of Korea"],"journal":["Pharmaceutics"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11207964"],"repository":["biostudies-literature"],"pubmed_title":["In Vivo Evaluation of 68Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model"],"pmcid":["PMC11207964"],"funding_grant_id":["2020M2D9A1093991","50462-2024","2023R1A2C1007307"],"pubmed_authors":["Cho Y","Lim S","Kang W","Park J","Lim J","Lee Y","Kang J","Lee T","Lee D"],"additional_accession":[]},"is_claimable":false,"name":"In Vivo Evaluation of 68Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model","description":null,"dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jun","modification":"2025-04-04T21:22:01.873Z","creation":"2025-04-04T21:22:01.873Z"},"accession":"S-EPMC11207964","cross_references":{}}